Ablation Technology Market Size

  • Report ID: 2971
  • Published Date: Sep 25, 2024
  • Report Format: PDF, PPT

Ablation Technology Market Size

Ablation Technology Market size was valued at USD 5.74 billion in 2023 and is set to exceed USD 18.24 billion by the end of 2036, expanding at over 9.3% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of ablation technology is evaluated at USD 6.17 billion.

Across the globe, ablation procedures are gaining rapid popularity since they are used in minimally invasive ablation procedures. Lower risk of damage to tissues, less risk of infection, quick recovery, and cost-effectiveness of ablation are some of the primary drivers of this market. Growing adoption of ablation procedures in emerging economies such as India, China, Russia, and Brazil, owing to the presence of high unmet medical needs and rising per capita healthcare expenditure in these countries, is estimated to fuel the market growth. The increasing incidence of chronic diseases such as cancer, cardiovascular diseases, and others also contributes to the market's growth. According to the World Health Organisation data, cancer accounted for nearly 10 million deaths in 2020, and 17.9 million people die each year from cardiovascular diseases.


Global-Ablation-Technology-Market
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 2971
  • Published Date: Sep 25, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rising occurrence of chronic disease such as cancer and emergence of next-generation ablation products and Technologies are the key factors driving market growth.

The market is anticipated to attain a moderate CAGR over the forecast period, i.e., 2021-2029.

Pricing and reimbursement issues and increasing regulatory agencies pressures are estimated to hamper market growth.

The market in Asia Pacific region will provide ample growth opportunities owing to factors such as increasing awareness, growing population, increasing income, eating habits, changing lifestyles, etc.

The major players dominating the non-metastatic castration resistant prostate cancer treatment market are Medtronic PLC, Biosense Webster Inc., St. Jude Medical, Inc., Boston Scientific Corporation, Angiodynamics, Inc., Atricure, Inc., Conmed Corporation, Olympus Corporation and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample